Abstract:METTL3 and METTL14 are traditionally posited to assemble the m6A methyltransferase complex in a stoichiometric 1:1 ratio, modulating mRNA fate via m6A modifications. Nevertheless, recent investigations reveal inconsistent expression levels and prognostic significance of METTL3 and METTL14 across various tumor types, challenging their consistent functional engagement in neoplastic contexts. A pan-cancer analysis leveraging The Cancer Genome Atlas (TCGA) data has identified pronounced disparities in the expression patterns, functional roles, and correlations with tumor burden between METTL3 and METTL14, particularly in esophageal squamous cell carcinoma (ESCC). Knockdown experiments of METTL3 in EC109 cells markedly suppress cell proliferation both in vitro and in vivo, whereas METTL14 knockdown shows a comparatively muted effect on proliferation and does not significantly alter METTL3 protein levels. mRNA sequencing indicates that METTL3 singularly governs the expression of 1615 genes, with only 776 genes co-regulated with METTL14. Additionally, immunofluorescence co-localization studies suggest discrepancies in cellular localization between METTL3 and METTL14. High-performance liquid chromatography-mass spectrometry (HPLC-MS) analyses demonstrate that METTL3 uniquely associates with the Nop56p-linked pre-rRNA complex and mRNA splicing machinery, independent of METTL14. Preliminary bioinformatics and multi-omics investigations reveal that METTL3's autonomous role in modulating tumor cell proliferation and its involvement in mRNA splicing are potentially pivotal molecular mechanisms. Our study lays both experimental and theoretical groundwork for a deeper understanding of the m6A methyltransferase complex and the development of targeted tumor therapies focusing on METTL3.

A novel interaction between RNA m6A methyltransferase METTL3 and RREB1

A METTL3–METTL14 Complex Mediates Mammalian Nuclear RNA N 6 -Adenosine Methylation

METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey

METTL5, an 18S Rrna-Specific M6a Methyltransferase, Modulates Expression of Stress Response Genes

SUMOylation of the M6a-Rna Methyltransferase METTL3 Modulates Its Function.

METTL3 plays a crucial function in multiple biological processes

Dynamic control of chromatin-associated m6A methylation regulates nascent RNA synthesis

Structural Basis for METTL6-mediated M3c RNA Methylation.

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Critical Roles of METTL3 in Translation Regulation of Cancer

Unraveling the independent role of METTL3 in m6A modification and tumor progression in esophageal squamous cell carcinoma

Solution Structure of the RNA Recognition Domain of METTL3-METTL14 N6-methyladenosine Methyltransferase

RNA m 6 A regulates transcription via DNA demethylation and chromatin accessibility

M(6)A Deposition Is Regulated By Prmt1-Mediated Arginine Methylation Of Mettl14 In Its Disordered C-Terminal Region

The catalytic mechanism of the RNA methyltransferase METTL3

METTL3 regulates heterochromatin in mouse embryonic stem cells

RNA Binding by the m6A Methyltransferases METTL16 and METTL3

PRMT1 methylates METTL14 to modulate its oncogenic function

New insights into the dynamics of m6A epitranscriptome: hybrid-seq identifies novel mRNAs of the m6A writers METTL3/14

METTL14 is a Chromatin Regulator Independent of Its RNA N 6-Methyladenosine Methyltransferase Activity

METTL3-Mediated RNA m6A Modification Regulates the Angiogenic Behaviors of Retinal Endothelial Cells by Methylating MMP2 and TIE2